Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.470
-0.090 (-3.52%)
Apr 29, 2026, 12:59 PM EDT - Market open
Moleculin Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 8.88 | 4.28 | 23.55 | 43.15 | 70.9 | Upgrade
|
| Cash & Short-Term Investments | 8.88 | 4.28 | 23.55 | 43.15 | 70.9 | Upgrade
|
| Cash Growth | 107.53% | -81.83% | -45.42% | -39.15% | 367.30% | Upgrade
|
| Other Receivables | 0.01 | 0.02 | 0.1 | 0.02 | 0.05 | Upgrade
|
| Receivables | 0.01 | 0.02 | 0.1 | 0.02 | 0.05 | Upgrade
|
| Prepaid Expenses | 0.52 | 0.57 | 2.08 | 1.63 | 1.06 | Upgrade
|
| Other Current Assets | 0.28 | 0.33 | 0.55 | 0.8 | 0.49 | Upgrade
|
| Total Current Assets | 9.69 | 5.19 | 26.27 | 45.6 | 72.5 | Upgrade
|
| Property, Plant & Equipment | 0.39 | 0.58 | 0.8 | 0.68 | 0.45 | Upgrade
|
| Other Intangible Assets | 11.15 | 11.15 | 11.15 | 11.15 | 11.15 | Upgrade
|
| Other Long-Term Assets | 0.9 | - | - | - | - | Upgrade
|
| Total Assets | 22.13 | 16.93 | 38.22 | 57.42 | 84.09 | Upgrade
|
| Accounts Payable | 3.51 | 2.03 | 2.5 | 2.1 | 1.36 | Upgrade
|
| Accrued Expenses | 3.21 | 3.21 | 4.22 | 2.61 | 2.16 | Upgrade
|
| Current Portion of Leases | 0.14 | 0.12 | 0.1 | 0.12 | 0.1 | Upgrade
|
| Total Current Liabilities | 6.85 | 5.36 | 6.82 | 4.82 | 3.62 | Upgrade
|
| Long-Term Leases | 0.22 | 0.36 | 0.47 | 0.34 | 0.06 | Upgrade
|
| Other Long-Term Liabilities | 0.04 | - | 4.86 | 0.08 | 1.41 | Upgrade
|
| Total Liabilities | 7.12 | 5.72 | 12.14 | 5.23 | 5.1 | Upgrade
|
| Common Stock | 0 | - | 0.03 | 0.03 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 221 | 183.69 | 157.65 | 153.99 | 151.73 | Upgrade
|
| Retained Earnings | -206 | -172.44 | -131.6 | -101.84 | -72.81 | Upgrade
|
| Comprehensive Income & Other | 0.01 | -0.04 | -0.01 | 0.01 | 0.04 | Upgrade
|
| Shareholders' Equity | 15.01 | 11.21 | 26.07 | 52.19 | 78.99 | Upgrade
|
| Total Liabilities & Equity | 22.13 | 16.93 | 38.22 | 57.42 | 84.09 | Upgrade
|
| Total Debt | 0.36 | 0.48 | 0.57 | 0.45 | 0.16 | Upgrade
|
| Net Cash (Debt) | 8.52 | 3.8 | 22.98 | 42.69 | 70.74 | Upgrade
|
| Net Cash Growth | 124.18% | -83.46% | -46.18% | -39.65% | 374.92% | Upgrade
|
| Net Cash Per Share | 7.19 | 27.59 | 290.75 | 559.72 | 987.09 | Upgrade
|
| Filing Date Shares Outstanding | 5.34 | 0.56 | 0.09 | 0.08 | 0.08 | Upgrade
|
| Total Common Shares Outstanding | 3.2 | 0.14 | 0.09 | 0.08 | 0.08 | Upgrade
|
| Working Capital | 2.83 | -0.17 | 19.46 | 40.78 | 68.88 | Upgrade
|
| Book Value Per Share | 4.69 | 82.93 | 292.62 | 683.66 | 1036.53 | Upgrade
|
| Tangible Book Value | 3.86 | 0.06 | 14.93 | 41.04 | 67.85 | Upgrade
|
| Tangible Book Value Per Share | 1.21 | 0.44 | 167.51 | 537.63 | 890.25 | Upgrade
|
| Machinery | 1.18 | 1.16 | 1.17 | 1.04 | 0.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.